Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jochen Hefner, Sara Berberich, Elena Lanvers, Maria Sanning, Ann-Kathrin Steimer & Volker Kunzmann. (2018) Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center. Patient Preference and Adherence 12, pages 1875-1887.
Read now
Read now
Articles from other publishers (17)
Masanari TsujiRyota TsukiokaMiya Oishi. (2023) Patient Safety Management Practiced by Pharmacy Pharmacists Using Their Training at Oncology Hospitalがん専門病院での研修を生かして，薬局薬剤師が実践する患者安全管理. YAKUGAKU ZASSHI 143:3, pages 223-228.
Crossref
Crossref
Yohei Iimura, Naoki Furukawa, Masaaki Ishibashi, Yuka Ahiko, Taro Tanabe, Susumu Aikou, Dai Shida, Masanori Nojima, Seiichiro Kuroda & Narikazu Boku. (2022) Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study). BMC Gastroenterology 22:1.
Crossref
Crossref
Nobuhiko Nakamura, Hiroki Shiraiwa, Yasuhiro Haruna, Tomoki Ichijima, Tomoko Takeda, Koji Hasegawa, Masaaki Kusumoto & Yoshitaka Yano. (2021) Effectiveness of protocol-based pharmacotherapy management collaboration between hospital and community pharmacists to address capecitabine-related hand–foot syndrome in cancer patients: a retrospective study. Journal of Pharmaceutical Health Care and Sciences 7:1.
Crossref
Crossref
Mingming Li, Jiani Chen, Yi Deng, Tao Yan, Haixia Gu, Yanjun Zhou, Houshan Yao, Hua Wei & Wansheng Chen. (2021) Risk prediction models based on hematological/body parameters for chemotherapy-induced adverse effects in Chinese colorectal cancer patients. Supportive Care in Cancer 29:12, pages 7931-7947.
Crossref
Crossref
Mingming Li, Xiaomeng Sun, Houshan Yao, Wei Chen, Feng Zhang, Shouhong Gao, Xun Zou, Jiani Chen, Shi Qiu, Hua Wei, Zhiqian Hu & Wansheng Chen. (2021) Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients. Toxicology and Applied Pharmacology 427, pages 115657.
Crossref
Crossref
Kazuyoshi Kawakami, Takeshi Aoyama, Takashi Yokokawa, Kazuo Kobayashi, Daisuke Takahari, Keisho Chin, Tsugumi Ide, Yoshiaki Machida, Kensei Yamaguchi & Toshihiro Hama. (2021) The Combined Use of 5 or More Drugs Is a Factor Related to Lower Adherence to S-1 in S-1 and Oxaliplatin Treatment for Advanced Gastric Cancer. Biological and Pharmaceutical Bulletin 44:8, pages 1075-1080.
Crossref
Crossref
Marina Sáez‐Belló, Víctor Mangas‐Sanjuán, Mª. Amparo Martínez‐Gómez, Mª. Ángeles López‐Montenegro Soria, Mónica Climente‐Martí & Matilde Merino‐Sanjuán. (2020) Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing recommendations. British Journal of Clinical Pharmacology 87:3, pages 905-915.
Crossref
Crossref
Junya Sato, Hiroshi Ishikawa, Yoko Yasuda, Rei Tanaka, Yoshio Kiyohara, Yuki Yamawaki, Megumi Endo & Michihiro Shino. (2020) Effectiveness of a pharmaceutical instruction video for adherence to dermatopathy treatment in patients with cancer receiving the anti-epidermal growth factor receptor antibody. Journal of Oncology Pharmacy Practice 26:7, pages 1667-1675.
Crossref
Crossref
Thomas Aparicio, Florence Canouï-Poitrine, Philippe Caillet, Eric François, Tristan Cudennec, Elisabeth Carola, Gilles Albrand, Anne-Marie Bouvier, Camille Petri, Bérengère Couturier, Jean-Marc Phelip, Leila Bengrine-Lefevre & Elena Paillaud. (2020) Treatment guidelines of metastatic colorectal cancer in older patients from the French Society of Geriatric Oncology (SoFOG). Digestive and Liver Disease 52:5, pages 493-505.
Crossref
Crossref
Hong-Tao Fu, Ying-Ying Xu, Jing-Jing Tian, Jia-Xin Fu, Shao-Ling Nie, Yan-Yan Tang, Ping Chen & Liang Zong. (2020) Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis. World Journal of Meta-Analysis 8:1, pages 27-40.
Crossref
Crossref
Eric Vachon, Barbara Given, Charles Given & Susann Dunn. (2019) Temporary Stoppages and Burden of Treatment in Patients With Cancer. Oncology Nursing Forum 46:5, pages E135-E144.
Crossref
Crossref
. 2019. Demystifying Drug Dosing in Renal Dysfunction. Demystifying Drug Dosing in Renal Dysfunction
153
170
.
Yun Hwa Jung, Jae Young Kim, Yu Na Jang, Sang Hoon Yoo, Gyo Hui Kim, Kang Min Lee, In Kyu Lee, Su Mi Chung & In Sook Woo. (2018) Clinical characteristics and treatment propensity in elderly patients aged over 80 years with colorectal cancer. The Korean Journal of Internal Medicine 33:6, pages 1182-1193.
Crossref
Crossref
Aaron Sha, Shirin Abadi & Sharlene Gill. (2017) Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study. Journal of Oncology Pharmacy Practice 24:7, pages 501-506.
Crossref
Crossref
Olivia Le Saux, Aurélie Bourmaud, Catherine Rioufol, Olivier Colomban, Jérôme Guitton, Vérane Schwiertz, Véronique Regnier, Benoit You, Florence Ranchon, Raymonde Maraval-Gaget, Pascal Girard, Franck Chauvin, Gilles Freyer, Michel Tod, Emilie Henin & Véronique Trillet-Lenoir. (2018) Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients. Cancer Chemotherapy and Pharmacology 82:2, pages 319-327.
Crossref
Crossref
Laura A. Fennimore & Pamela K. Ginex. (2017) Oral Agents for Cancer Treatment. Nursing Clinics of North America 52:1, pages 115-131.
Crossref
Crossref
Kazuo Sugita, Kazuyoshi Kawakami, Takashi Yokokawa, Takahito Sugisaki, Tomomi Takiguchi, Takeshi Aoyama, Kenichi Suzuki, Mitsukuni Suenaga, Kensei Yamaguchi, Ayaka Inoue, Yoshiaki Machida, Toshiharu Yamaguchi & Toshihiro Hama. (2016) Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study. Oncology 91:4, pages 224-230.
Crossref
Crossref